Strategic Advisory Group of Experts on Immunization (SAGE)

Strategic Advisory Group of Experts on Immunization (SAGE)

The Strategic Advisory Group of Experts on Immunization (SAGE) is charged with advising WHO on overall global policies and strategies, ranging from vaccines and technology, research and development, to delivery of immunization and its linkages with other health interventions.

About us

COVID-19 vaccines technical documents

Covid-19 vaccine platform specific recommendations

mRNA vaccines platform

All

Interim recommendations for the use of mRNA COVID-19 vaccines19 July 2023

Pfizer–BioNTech BNT162b2 vaccine

Annexes

Annexes Pfizer–BioNTech BNT162b2 vaccine18 August 2022

Archived documents

Background Pfizer–BioNTech BNT162b2 vaccine15 January 2021

Moderna mRNA-1273 vaccine

Annexes

Annexes Moderna mRNA-1273 vaccine 18 August 2022

Archived documents

Background Moderna mRNA-1273 vaccine3 February 2021

Inactivated vaccines platform

All

Interim recommendations for the use of inactivated COVID-19 vaccines31 August 2023

Bharat BBV152 Covaxin vaccine

Annexes

Annexes Bharat BBV152 vaccine15 March 2022

Archived documents

Recommendations Bharat BBV152 vaccine15 March 2022

Background Bharat BBV152 vaccine3 November 2021

Valneva VLA2001 vaccine against COVID-19

Annexes

Annexes to the interim recommendations for use of the Valneva VLA200118 August 2022

Archived documents

Interim recommendations for use of the Valneva VLA2001 vaccine18 August 2022

Background document on the Valneva VLA2001 vaccine18 August 2022

Sinovac-CoronaVac vaccine

Annexes

Annexes Sinovac-CoronaVac vaccine15 March 2022

Archived documents

Recommendations Sinovac-CoronaVac vaccine15 March 2022

Background Sinovac-CoronaVac vaccine24 May 2021

Sinopharm COVID-19 vaccine BIBP

Annexes

Annexes COVID-19 vaccine BIBP15 March 2022

Archived documents

Recommendations COVID-19 vaccine BIBP15 March 2022

Background COVID-19 vaccine BIBP07 May 2021

Vectored vaccines platform

All

Janssen Ad26.COV2.S (COVID-19) vaccine

Updated recommendations Janssen Ad26.COV2.S vaccine6 June 2022

Annexes Janssen Ad26.COV2.S vaccine6 June 2022

Background Janssen Ad26.COV2.S vaccine17 March 2021

ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222, SII Covishield)

Updated recommendations AZD1222 (‎ChAdOx1-S [‎recombinant]‎)‎ vaccine 15 March 2022

Annexes AZD1222 (‎ChAdOx1-S [‎recombinant]‎)‎ vaccine 15 March 2022

Technical note on delayed shipments for the ChAdOx1-S [recombinant] vaccines26 May 2021

Background AZD1222 (‎ChAdOx1-S [‎recombinant]‎)‎ vaccine 1 March 2021

Cansino Ad5-nCoV-S vaccine against COVID-19

Recommendations Cansino Ad5-nCoV-S vaccine19 May 2022

Annexes Cansino Ad5-nCoV-S vaccine19 May 2022

Background Cansino Ad5-nCoV-S vaccine19 May 2022

Protein subunit vaccines platform

All

Interim recommendations for the use of protein subunit COVID-19 vaccines31 August 2023

Novavax / Serum Institute of India
NVX-CoV2373 vaccine against COVID-19

Annexes

Annexes to the interim recommendations for the Novavax NVX-CoV2373 vaccine27 September 2022

Archived documents

Background Novavax NVX-CoV2373 vaccine20 December 2021

Interim recommendations for the Novavax NVX-CoV2373 vaccine27 September 2022

Biological E Limited’s Corbevax (‎BECOV-2)‎ vaccine against COVID-19

Annexes

Annexes to the recommendations for use of the Biological E Limited’s Corbevax (BECOV-2) vaccine against COVID-1925 September 2023

Cross-cutting policy-making guidance on COVID-19 vaccines

10 November 2023

WHO SAGE Roadmap for prioritizing uses of COVID-19 vaccines

2 November 2023

Good practice statement on the use of variant-containing COVID-19 vaccines

Good practice statement on the use of second booster doses for COVID-19 vaccines

16 December 2021

Interim recommendations for heterologous COVID-19 vaccine schedules

25 October 2021

Interim recommendations for an extended primary series with an additional vaccine dose for COVID-19 vaccination in immunocompromised persons

21 October 2021

Coadministration of seasonal inactivated influenza and COVID-19 vaccines

10 December 2020

Evidence to recommendations for COVID-19 vaccines: Evidence framework

14 October 2020

Critical Evidence Questions For COVID-19 Vaccines Policy Making

13 September 2020

WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination

Prioritized Infectious Disease and Economic Modelling Questions

Other COVID-19 related guidance

Critical Sex and Gender Considerations for Equitable Research, Development and Delivery of COVID-19 Vaccines

20 September 2020

WHO SAGE Seasonal Influenza Vaccination Recommendations during the COVID-19 Pandemic

Further resources

COVID-19 vaccine introduction toolkit